ATE188385T1 - Antithrombin iii - präparation - Google Patents

Antithrombin iii - präparation

Info

Publication number
ATE188385T1
ATE188385T1 AT93115422T AT93115422T ATE188385T1 AT E188385 T1 ATE188385 T1 AT E188385T1 AT 93115422 T AT93115422 T AT 93115422T AT 93115422 T AT93115422 T AT 93115422T AT E188385 T1 ATE188385 T1 AT E188385T1
Authority
AT
Austria
Prior art keywords
antithrombin iii
preparation
powder
solvent
alkyl ester
Prior art date
Application number
AT93115422T
Other languages
English (en)
Inventor
Toshinobu Aoyama
Keizou Hirahara
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17402131&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE188385(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of ATE188385T1 publication Critical patent/ATE188385T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT93115422T 1992-10-02 1993-09-24 Antithrombin iii - präparation ATE188385T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26436492A JP3494667B2 (ja) 1992-10-02 1992-10-02 アンチトロンビンｉｉｉ製剤

Publications (1)

Publication Number Publication Date
ATE188385T1 true ATE188385T1 (de) 2000-01-15

Family

ID=17402131

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93115422T ATE188385T1 (de) 1992-10-02 1993-09-24 Antithrombin iii - präparation

Country Status (12)

Country Link
US (1) US5385890A (de)
EP (1) EP0590531B1 (de)
JP (1) JP3494667B2 (de)
KR (1) KR100264707B1 (de)
AT (1) ATE188385T1 (de)
AU (1) AU672430B2 (de)
CA (1) CA2107516C (de)
DE (1) DE69327498T2 (de)
DK (1) DK0590531T3 (de)
ES (1) ES2141123T3 (de)
GR (1) GR3032580T3 (de)
PT (1) PT590531E (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2137258A1 (en) * 1993-04-05 1994-10-13 Yoshitomi Pharmaceutical Industries Ltd. Liquid preparation of antithrombin-iii and stabilizing method therefor
AT405905B (de) * 1997-03-25 1999-12-27 Immuno Ag Neue verwendung von antithrombin iii
US6518406B1 (en) * 1999-06-23 2003-02-11 Octapharma Ag Method for purification of proteins
CN114813287A (zh) * 2022-06-29 2022-07-29 深圳市帝迈生物技术有限公司 一种用于肝素抗凝检测的校准品及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597693B2 (ja) * 1978-01-07 1984-02-20 株式会社ミドリ十字 抗トロンビン製剤及びその製法
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
US5319072A (en) * 1992-01-10 1994-06-07 Alpha Therapeutic Corporation Human antithrombin-III preparation

Also Published As

Publication number Publication date
EP0590531B1 (de) 2000-01-05
GR3032580T3 (en) 2000-05-31
DE69327498T2 (de) 2000-06-08
PT590531E (pt) 2000-05-31
EP0590531A1 (de) 1994-04-06
CA2107516C (en) 2004-12-07
DE69327498D1 (de) 2000-02-10
ES2141123T3 (es) 2000-03-16
DK0590531T3 (da) 2000-06-13
KR940008695A (ko) 1994-05-16
JP3494667B2 (ja) 2004-02-09
AU672430B2 (en) 1996-10-03
JPH06116167A (ja) 1994-04-26
KR100264707B1 (ko) 2000-09-01
US5385890A (en) 1995-01-31
AU4872893A (en) 1994-04-14
CA2107516A1 (en) 1994-04-03

Similar Documents

Publication Publication Date Title
LV10907A (lv) Interferona polietilenglikola atvasinajums
DE69132006D1 (de) Thiazolederivate als inhibitoren von aktivem sauerstoff
NZ239359A (en) Peptide-boronic acid derivatives as serine protease inhibitors
GR1001225B (el) Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους.
DE3380409D1 (de) Diazabicyclo(3.3.1)nonanes
BG37995A3 (en) Method for preparing derivatives of 2- cyanbenzimidazol
BG33296A3 (bg) Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид
JPS53119844A (en) Optically active amino acid-mandelic acid complexes and theire preparation
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
DE69314942D1 (de) N-acylglutamin-derivate
BG36348A3 (en) Method for preparing thienopyridinon derivatives
GR3021511T3 (en) Stable freeze dried polyhematoporphyrin ether/ester composition
TW348063B (en) A pharmaceutical composition in the form of plaster containing pranoprofen
ATE188385T1 (de) Antithrombin iii - präparation
DE69000719D1 (de) Hautreinigungsmittel.
BG37839A3 (bg) Метод за получаване на производни на ортокондензиран пирол
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
BG35749A3 (bg) Метод за получаване на 20-дихидро-20,23-дидеокситидонолид
ES2090835T3 (es) Calibrador y su uso en un ensayo inmunologico.
BG34454A3 (bg) Метод за получаване на производни на 7 бета- аминотиазолилацетамидо- 3- цефем- 4- карбоновата киселина
DE2960291D1 (en) Coumarin derivatives and their use as brightening agents for high molecular organic substances
JPS56118442A (en) Halogen-containing resin composition
BG35899A3 (bg) Метод за получаване на пеницилинови и цефалоспоринови иминохалогениди
ATE73812T1 (de) Thionophosphonsaeureester.
JPS5572116A (en) Anti-tumor agent

Legal Events

Date Code Title Description
RZN Patent revoked